PV Bulletin

Vaccine Lot Release: Notification of Non Compliance

NPRA (Malaysia) reports on compliance issues for several vaccine lots.

Primary source: Cancellation of Notified Cosmetic Products

PV Impact Brief

Urgency: HighConfidence: high

What changed

Issuance of non-compliance notifications for specific vaccine lots, including dates for COMIRNATY and MENACTRA. Notably, the compliance notifications detail issues impacting distribution.

Why it matters

This update is critical for regulatory compliance and safety management of vaccine products. Non-compliance could affect public health outcomes and regulatory obligations.

Action needed

Implement an immediate review of affected vaccine lots and ensure all relevant stakeholders are informed of the compliance issues for Signal Management processes.

Relevant for
Regulatory Intelligence Lead
Processes impacted
Signal Management
Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Evidence and confidence

Confidence: highSource updated: Aug 16, 2026

Full briefing

Practical implication

Implement an immediate review of affected vaccine lots and ensure all relevant stakeholders are informed of the compliance issues for Signal Management processes.

The National Pharmaceutical Regulatory Agency (NPRA) of Malaysia has issued notifications regarding non-compliance for various vaccine lots including COMIRNATY and MENACTRA. This affects the release and usage of these products.

What changed: Issuance of non-compliance notifications for specific vaccine lots, including dates for COMIRNATY and MENACTRA. Notably, the compliance notifications detail issues impacting distribution.

Why it matters: This update is critical for regulatory compliance and safety management of vaccine products. Non-compliance could affect public health outcomes and regulatory obligations.

Practical implication: Implement an immediate review of affected vaccine lots and ensure all relevant stakeholders are informed of the compliance issues for Signal Management processes.

View original source

  • Source: NPRA (Malaysia) - Press Releases
  • Published at source: 2026-08-16T06:30:49.000Z
  • Discovered by monitor: 2026-08-16T06:37:45.250Z

Published from the regulator source ingestion pipeline after PV impact triage.

#Safety Signal#Safety Signals#Malaysia#Source-ingestion#Regulator-monitor#Npra.gov.my

Related updates for your role

publicFDA · USA · Updated Sep 4, 2026

FDA Grants Accelerated Approval to Etcamah for Advanced Breast Cancer

Urgency: High

Regulatory teams must prepare for updating labeling to include details on the new indication and required diagnostic methods, along with planning for the confirmatory studies mandated by the FDA.

Signal ManagementLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicMHRA · UK · Updated Sep 4, 2026

Change to the definition of regulated activity with children from 1 September 2026

Urgency: High

Organizations must re-evaluate roles related to children's activities and prepare to request Enhanced DBS checks including access to the Children’s Barred List check starting from 1 September 2026.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicUK Health Security Agency · UK · Updated Sep 7, 2026

Low Flu Vaccination Rates Among Primary School Children

Urgency: High

Parents are reminded to complete and return flu vaccination consent forms promptly as vaccination sessions in schools are set to start this week, aiming for completion by late November.

Signal ManagementPV Quality Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: PV Quality Lead, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Recall of Gore Viabahn Endoprosthesis with Bioactive Heparin Coating

Urgency: High

Health establishments receiving affected devices must be notified, and protocols established to ensure compliance with the recall.

Signal ManagementQPPV
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: QPPV, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward